National Bank of Canada’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $125 | Sell |
230
-2,051
| -90% | -$1.12K | ﹤0.01% | 2484 |
|
2025
Q1 | $1.48K | Sell |
2,281
-420
| -16% | -$273 | ﹤0.01% | 2208 |
|
2024
Q4 | $2.76K | Buy |
2,701
+2,501
| +1,251% | +$2.55K | ﹤0.01% | 2161 |
|
2024
Q3 | $173 | Hold |
200
| – | – | ﹤0.01% | 2346 |
|
2024
Q2 | $67 | Hold |
200
| – | – | ﹤0.01% | 2492 |
|
2024
Q1 | $110 | Hold |
200
| – | – | ﹤0.01% | 2471 |
|
2023
Q4 | $111 | Hold |
200
| – | – | ﹤0.01% | 2469 |
|
2023
Q3 | $120 | Hold |
200
| – | – | ﹤0.01% | 2487 |
|
2023
Q2 | $260 | Hold |
200
| – | – | ﹤0.01% | 2486 |
|
2023
Q1 | $350 | Hold |
200
| – | – | ﹤0.01% | 2469 |
|
2022
Q4 | $626 | Hold |
200
| – | – | ﹤0.01% | 2458 |
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 2448 |
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 2505 |
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 2559 |
|
2021
Q4 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 2455 |
|